Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Imunon, Inc. (IMNN) had Return on Equity of -205.26% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-14.49M |
|
-- |
|
-- |
|
$14.65M |
|
$-14.65M |
|
$0.16M |
|
$-14.49M |
|
$-14.49M |
|
$-14.49M |
|
$-14.49M |
|
$-14.49M |
|
$-14.49M |
|
$-14.65M |
|
$-13.95M |
|
2.12M |
|
2.12M |
|
$-6.83 |
|
$-6.83 |
|
| Balance Sheet Financials | |
$10.72M |
|
$0.53M |
|
$1.56M |
|
$12.29M |
|
$4.62M |
|
-- |
|
$0.60M |
|
$5.23M |
|
$7.06M |
|
$7.06M |
|
$7.06M |
|
3.42M |
|
| Cash Flow Statement Financials | |
$-13.90M |
|
$-0.28M |
|
$17.09M |
|
$5.87M |
|
$8.78M |
|
$2.91M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-205.26% |
-205.26% |
|
-117.96% |
|
-205.26% |
|
$2.06 |
|
$-6.68 |
|
$-6.54 |
|